Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluoro phenyl)-3- quinoline-base]-2,2-dimethyl-1,3-dioxane-6- heptene acid tert-butyl ester |
147489-06-3 | - / 99.9% | Inquiry | |
(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)- 3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid tertbutyl ester |
586966-54-3 | - / 99.9% | Inquiry | |
2-n-propyl-4-methyl-6-(1- methylbenzimidazole-2-ly)benzimidazole |
2,5′-Bi-1H-benzimidazole,1,7′-dimethyl-2′-propyl-;1,7′-Dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole;2-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole;4-Methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole;1,7′-Dimethyl-2′-propyl-2,5′-bibenzimidazole;2-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole;1,7′-Dimethyl-2′-propyl-1H,1′H-2,5′-bibenzo[d]imidazole;2-n-Propyl-4-methyl-6-(1′-methylbenzimidazole-2-yl)benzimidazole |
152628-02-9 | - / 99.9% | Inquiry |
Celecoxib CAS169590-42-5 |
Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;Celecoxib;SC 58635;YM 177;Celebrex;Celocoxib;Celebra;Celecox;Xilebao;Medicoxib;Eurocox;Onsenal;4-[5-(p-Tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;184007-95-2;194044-54-7 |
169590-42-5 | - / 99.9% | Inquiry |
flavoxate hydrochloride Flavoxate HCl (EP standard) 99.9% with DMF and GMP |
4H-1-Benzopyran-8-carboxylic acid,3-methyl-4-oxo-2-phenyl-,2-(1-piperidinyl)ethyl ester,hydrochloride (1:1);4H-1-Benzopyran-8-carboxylic acid,3-methyl-4-oxo-2-phenyl-,2-piperidinoethyl ester,hydrochloride;4H-1-Benzopyran-8-carboxylic acid,3-methyl-4-oxo-2-phenyl-,2-(1-piperidinyl)ethyl ester,hydrochloride;1-Piperidineethanol,3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate (ester),hydrochloride;Flavoxate hydrochloride;Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride;DW 61;Peflate;Rec 7/0040;Spasmal;Urispas;Bladderon;Genurin;Patricin;Spasuret;NSC 114649;2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride |
3717-88-2 | - / 99.9% | Inquiry |
Flunarizine HCl |
Piperazine,1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]-,hydrochloride (1:2);Piperazine,1-[bis(p-fluorophenyl)methyl]-4-cinnamyl-,dihydrochloride,(E)-;Piperazine,1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-,dihydrochloride,(E)-;Piperazine,1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]-,dihydrochloride;Flunarizine hydrochloride;Flunarizine dihydrochloride;R 14950;Gradient;Flugeral;Fluxarten;Dinaplex;Issium;Flunagen;Mondus;Flunarl;(E)-1-[Bis(4-fluorophenyl)methyl]-4-cinnamylpiperazine dihydrochloride |
30484-77-6 | - / 99.9% | Inquiry |
Glipizide(CEP) GMP standard: BP CP USP EP |
2-Pyrazinecarboxamide,N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-;Urea,1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]-;Pyrazinecarboxamide,N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-;N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide;N-(4-[β-(5-Methylpyrazine-2-carboxamido)ethyl]benzenesulfonyl)-N′-cyclohexylurea;Glydiazinamide;K 4024;Glipizide;TK 1320;Minidiab;Sucrazide;Glipid;Napizide;Mindiab;Glidiab;Glyde;Glupitel;Minodiab;Gluco-Rite;Glucotrol Xl;Ozidia;Dipazide;Melizide;Glynase;Glucotrol;Minidab;Glupizide;Aldiab;Digrin;Glucozide;Glibetin;Glucolip;Glibenese;Glican;CP 28720;Glipizid;Semiglynase;N-(2-(4-(N-(Cyclohexylcarbamoyl)sulfamoyl)phenyl)ethyl)-5-methylpyrazine-2-carboxamide;Samarium(III) ionophore I;29094-66-4;38777-27-4;172964-66-8 |
29094-61-9 | - / 100.3% | Inquiry |
Loxoprofen CAS 68767-14-6 |
Benzeneacetic acid,α-methyl-4-[(2-oxocyclopentyl)methyl]-;α-Methyl-4-[(2-oxocyclopentyl)methyl]benzeneacetic acid;Loxoprofen;2-[4-[(2-Oxocyclopentan-1-yl)methyl]phenyl]propionic acid;2-[4-[(2-Oxocyclopentyl)methyl]phenyl]propionic acid;2-[4-[(2-Oxocyclopentyl)methyl]phenyl]propanoic acid |
68767-14-6 | - / 99.9% | Inquiry |
CONTACT INFORMATION
Sign In for Details